Clinical trial
Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
NCT03632759
Study timeline
Study start (actual)2018-08-15Date precision: day
Registry last updated2022-01-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 1 Diabetes Mellitusunresolved
Interventions
LiraglutideDRUG · verified · RxNorm: liraglutide
GolimumabDRUG · verified · RxNorm: golimumab
Sponsors & collaborators
Carla Greenbaum, MDlead sponsor
Juvenile Diabetes Research Foundationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03632759 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.